ten23 health has been certified as a B Corporation, making it the first biotech CDMO to achieve this status.
The B Corp initiative acknowledges companies that meet rigorous social and environmental standards — specifically focusing on their performance, transparency and accountability.
Companies awarded with B Corp status voluntarily meet the highest Environmental, Social and Corporate Governance (ESG) standards.
As a newly certified B Corp, ten23 health joins a global movement of companies using “business as a force for good”.
ten23 health's CEO, Hanns-Christian Mahler, commented: “Companies like ours that operate in the pharmaceutical sector are used to the demands of a tightly regulated environment,”
“We believe that it is not enough simply to state ethical and environmental aspirations, but it is also critical to voluntarily achieve ambitious and recognised standards like the B Corp certification. After all, our marketplaces are reliant on top ethical standards to protect the environment, professionals and patients. It is our mission to leave a heart-print related to sustainability for our customers, other CDMOs and our employees alike, and I am proud and happy to see our Fairstainability agenda at ten23 health being validated by becoming a B Corp,”
“We are proud to have received the certification and hope to inspire other companies and CDMOs to do the same, putting fairness and sustainability as a top priority,’’ concluded Carole Schanté, Fairstainability Co-Officer at ten23 health.
